phenobarbital sodium contraindications for Dummies

phenobarbital sodium contraindications for Dummies

Blog Article

pentobarbital will lower the extent or effect of brexpiprazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Carefully. Double brexpiprazole dose over 1-2 months if administered with a solid CYP3A4 inducer.

pentobarbital will minimize the extent or effect of alosetron by impacting hepatic enzyme CYP2C9/10 metabolism. Small/Significance Not known.

Since this kind of people might be a lot less conscious of specific with the milder adverse effects of barbiturates, the incidence of those reactions could be somewhat larger in completely ambulatory clients.

pentobarbital will lessen the level or effect of lumacaftor/ivacaftor by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.

pentobarbital will decrease the extent or effect of stiripentol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. If unable to stay away from coadministration of stiripentol with strong CYP3A4 inducers, raise stiripentol dose.

Workout caution when administered to individuals with acute or Persistent ache; could result in paradoxical excitement or important symptoms might be masked

pentobarbital will decrease the extent or effect of isradipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unknown.

pentobarbital will reduce the extent or effect of methylprednisolone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

pentobarbital will reduce the extent or effect of nicardipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. read more Use Warning/Keep an eye on.

pentobarbital will lessen the extent or effect of trazodone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.

pentobarbital will lessen the level or effect of rolapitant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Prolonged-phrase coadministration of powerful CYP3A4 inducers with rolapitant might substantially decrease rolapitant efficacy.

pentobarbital will decrease the extent or effect of clarithromycin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unknown.

This mechanism is probably from the induction of hepatic microsomal enzymes that metabolize the antibiotic. If phenobarbital and doxycycline are administered concurrently, the scientific reaction to doxycycline must be monitored closely.

pentobarbital decreases levels of panobinostat by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Robust CYP3A4 inducers can cut down panobinostat stages by ~70% and result in cure failure.